ICH adopts E2D(R1) guideline on post-approval safety data

Regulatory NewsRegulatory NewsGlobalICHPharmaceuticalsPharmacovigilancePharmacovigilance/postmarket surveillanceRegulatory harmonizationRegulatory Intelligence/Policy